303 studies found for:    Encephalopathy
Show Display Options
RSS Create an RSS feed from your search for:
Encephalopathy
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Cerebrovascular Reactivity in Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention:
2 Completed Hyperproteic Diet Plus Lactobacillus Reuteri and Nitazoxanide in Minimal Hepatic Encephalopathy
Conditions: Hepatic Cirrhosis;   Minimal Hepatic Encephalopathy
Interventions: Other: Auxiliary Treatment;   Dietary Supplement: Hyperproteic and fiber-rich diet;   Drug: Nitazoxanide
3 Completed Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Dietary Supplement: Branched-chain amino acids;   Dietary Supplement: Maltodextrin
4 Not yet recruiting Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Interventions: Drug: Flumazenil;   Drug: Placebo
5 Completed Efficacy of Albumin for Acute Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Albumin;   Drug: Sodium chloride 0.9%
6 Unknown  Comparison Between Erythromycin and Neomycin Treatment of Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hypertension, Portal;   Liver Cirrhosis
Interventions: Drug: Erythromycin;   Drug: Neomycin
7 Not yet recruiting Lactulose, L-ornithine L-aspartate, or Rifaximin Versus Placebo for Preventing Hepatic Encephalopathy in Variceal Bleeding
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: L-ornithine L-aspartate;   Drug: Rifaximin;   Drug: Placebo
8 Not yet recruiting Brain Muscle Axis During Treatment of Hepatic Encephalopathy With L-ornithine L-aspartate
Conditions: Hepatic Encephalopathy;   Minimal Hepatic Encephalopathy;   Cirrhosis
Interventions: Procedure: Vastus Muscle Biopsy;   Drug: LOLA or placebo;   Other: Cognitive assessment (PHES);   Other: Cognitive Assessement (Cogstate);   Other: blood and urine sampling;   Other: Nutritional assessment;   Other: MRI brain and spectroscopy;   Other: MRI leg cross section;   Other: Functional MRI (working memory and attention tasks)
9 Recruiting Glutamine Challenge as Predictor of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Conditions: Refractory Ascites;   Hepatic Hydrothorax;   Hepatic Encephalopathy;   Cirrhosis
Interventions: Other: Oral glutamine challenge;   Other: Psychometric Tests
10 Unknown  The Role of Bacterial Overgrowth and Delayed Intestinal Transit in Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Hepatitis C;   Liver Cirrhosis
Intervention: Drug: Rifaximin (drug)
11 Completed Efficacy of L-Ornithine L-Aspartate in Acute Hepatic Encephalopathy.
Condition: Hepatic Encephalopathy
Interventions: Drug: L-ornithine-L-aspartate;   Drug: Lactose
12 Recruiting Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)
Conditions: Acute Episode of Overt Hepatic Encephalopathy;   Hepatic Encephalopathy
Interventions: Drug: ornithine phenylacetate;   Drug: placebo intravenous infusion
13 Unknown  Secondary Prophylaxis of Hepatic Encephalopathy in Cirrhosis
Condition: Hepatic Encephalopathy
Interventions: Drug: Lactulose;   Drug: Probiotics(VSL#3)
14 Unknown  Effect of Lactose in Patients With Chronic Liver Disease and Minimal Hepatic Encephalopathy
Conditions: Hepatic Encephalopathy;   Liver Cirrhosis
Intervention: Dietary Supplement: whole milk vs lactose-free milk
15 Unknown  Primary Prophylaxis of Hepatic Encephalopathy in Patients With Cirrhosis
Condition: Hepatic Encephalopathy
Intervention: Drug: Lactulose
16 Completed Effect of Lactulose on Minimal Hepatic Encephalopathy and Health-Related Quality of Life
Conditions: Minimal Hepatic Encephalopathy;   Hepatic Encephalopathy
Intervention: Drug: Lactulose
17 Active, not recruiting Late Hypothermia for Hypoxic-Ischemic Encephalopathy
Conditions: Infant, Newborn;   Hypoxia, Brain;   Hypoxia-Ischemia, Brain;   Encephalopathy, Hypoxic-Ischemic;   Hypoxic-Ischemic Encephalopathy;   Ischemic-Hypoxic Encephalopathy
Interventions: Procedure: Hypothermia;   Procedure: Normothermic Control
18 Withdrawn Efficacy and Safety Study of Ammonul® in Patients With Grade 3 or 4 Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: sodium phenylacetate and sodium benzoate injection 10% / 10%;   Drug: placebo solution (10% dextrose)
19 Completed Post Transjugular Intrahepatic Portosystemic Shunt (Tips) Albumine Infusion to Prevent Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Intervention: Drug: Albumin
20 Recruiting The Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy
Condition: Hepatic Encephalopathy
Interventions: Drug: Placebo;   Drug: Rifaximin

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years